First Death from Pfizer Vaccine Side Effects Reported in New Zealand

[Image source=EPA Yonhap News]

[Asia Economy Reporter Kim Suhwan] The first death related to side effects from the Pfizer vaccine has occurred in New Zealand.

On the 30th, the New Zealand Ministry of Health disclosed that it received a report from the COVID-19 Safety Monitoring Board (CV-ISMB) stating that a woman who received the Pfizer vaccine died from myocarditis.

Myocarditis is one of the rare side effects of the Pfizer vaccine.

The independent body CV-ISMB stated, "Myocarditis is believed to have been caused by the vaccine," adding, "Other medical conditions may have also contributed to this outcome."

CV-ISMB confirmed, "This is the first death related to vaccination in New Zealand and is associated with the Pfizer vaccine."

Dr. John Tate, chair of CV-ISMB, emphasized that despite this, health authorities remain confident in using the Pfizer vaccine in New Zealand, stating, "The Pfizer vaccine is highly effective in protecting us from the serious risks of COVID-19."

Previously, New Zealand authorities had approved the emergency use of the Pfizer vaccine along with the Janssen and AstraZeneca vaccines.

Meanwhile, New Zealand reported 53 new community COVID-19 cases on the day, about 30 fewer than the previous day.

All cases occurred in Auckland.

Since the 17th, the total number of community infections in New Zealand stands at 562, with 547 cases in Auckland and 15 in Wellington.

This content was produced with the assistance of AI translation services.